Evidence map›Paper›PMID 32567174›Full record

ArticleThoracic cancer2020

Follow-up of an occult tuberculosis scar cancer after resection of metastatic lesions.

Mengyao Sun, Yinghui Xu, Xu Wang, Chao Sun, Ye Guo, Guoguang Shao, Zhiguang Yang, Yunpeng Liu, Peng Zhang, Shi Qiu and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Mengyao SunCancer Center, The First Hospital of Jilin University, Changchun, China.
Yinghui XuCancer Center, The First Hospital of Jilin University, Changchun, China.
Xu WangCancer Center, The First Hospital of Jilin University, Changchun, China.
Chao SunCancer Center, The First Hospital of Jilin University, Changchun, China.
Ye GuoCancer Center, The First Hospital of Jilin University, Changchun, China.
Guoguang ShaoThoracic Surgery Department, The First Hospital of Jilin University, Changchun, China.
Zhiguang YangThoracic Surgery Department, The First Hospital of Jilin University, Changchun, China.
Yunpeng LiuThoracic Surgery Department, The First Hospital of Jilin University, Changchun, China.
Peng ZhangThoracic Surgery Department, The First Hospital of Jilin University, Changchun, China.
Shi QiuCancer Center, The First Hospital of Jilin University, Changchun, China.
Kewei MaCancer Center, The First Hospital of Jilin University, Changchun, China.ORCID 0000-0003-2987-576X
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 61-year-old Chinese man with a history of tuberculosis was found to have a large mass in the left lower lobe and multiple ground-glass nodules (GGNs) on lung computed tomography (CT). Post-operative pathology showed lung squamous carcinoma in the left lower lobe and mediastinal lymph node metastases, which were confirmed as lung adenocarcinoma. Multiple gene sequencing was performed, and no relationship was observed between the two primary sites. Chemotherapy consisting of four cycles of gemcitabine plus cisplatin were prescribed for this patient after the operation. After a period of two-year follow-up, the lung adenocarcinoma was found to have progressed with new metastases in the right cervical lymph nodes which had the same pathology and gene mutation as the metastatic mediastinal lymph nodes removed two years previously. Meanwhile, a primary lesion was found following PET-CT scan, and the tuberculosis scar was determined as its point of origin. In conclusion, we have found that a tuberculosis scar is a risk factor of lung cancer, especially adenocarcinoma, and more attention should be paid to close monitoring and follow-up by clinicians.

Indexed as

CicatrixHumansMaleMiddle AgedNeoplasm MetastasisSurgical Procedures, OperativeTuberculosisEGFR mutationlung cancer of unknown primary (CUP)metastatic lymph nodestuberculosis scar cancer

Identifiers

PMID32567174
PMCPMC7396367
OpenAlexW3036090887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.